Lung cancer was diagnosed in this patient despite no visible tumor mass on lung imaging. The diagnosis was confirmed through immunocytochemical testing of pleural fluid. No surgery was performed. After 18 months of targeted therapy, resistance developed and the disease gradually spread. The patient died at the 30-month mark.
Death
Survival of 30 months in lung cancer presenting with malignant pleural effusion is considered above-average. If we examine potential shortcomings, the following points emerge: First, the patient actually began taking Icotinib during this hospitalization, yet the discharge summary made no mention of EGFR testing. Second, as many as five CT scans were performed during the hospital stay. In several cases, the discharge summary provided no clear justification for the necessity of those examinations. Third, the imaging reports did not clearly map onto the clinical treatment pathway, seemingly avoiding discussion of surgical suitability. Fourth, information from the mediastinal window of the CT scans was missing. Although malignant pleural effusion ruled out surgical appropriateness, the biases reflected in the medical records remain objectively present.
The patient was diagnosed with advanced lung cancer after coughing for six months. He should have contacted this website as soon as the cough began. Reaching out to this website at the same time as seeking medical care was his only real chance.